Affiliations: [a] Department of Molecular Biomedicine, Center for Research and Advanced Studies (CINVESTAV), CDMX, México | [b] Dementia Research Centre, Department of Neurodegenerative Diseases, UCL Institute of Neurology, London, UK
| [c] VIB-KU Leuven Center for Brain & Disease Research, Leuven, Belgium
| [d] Department of Neurosciences, Leuven Research Institute for Neuroscience and Disease (LIND), KU Leuven, Leuven, Belgium
Correspondence:
[*]
Correspondence to: Marco Antonio Meraz-Ríos, PhD, Avenida Instituto Politécnico Nacional 2508, San
Pedro Zacatenco CP 07360, CDMX, México. E-mail: [email protected].
Abstract: Presenilin 1 gene (PSEN1) mutations are the most common cause of familial Alzheimer’s disease (FAD). One of the most abundant FAD mutations, PSEN1 A431E, has been reported to be associated with spastic paraparesis in about half of its carriers, but the determining mechanisms of this phenotype are still unknown. In our study we characterized three A431E mutation carriers, one symptomatic and two asymptomatic, from a Mexican family with a history of spastic paraparesis in all of its affected members. At cognitive assessment and MRI, the symptomatic subject showed an atypical non-amnestic mild cognitive impairment with visuospatial deficits, olfactory dysfunction and significant parieto-occipital brain atrophy. Furthermore, we found several periventricular white matter hyperintensities whose progression pattern and localization correlated with their motor impairment, cognitive profile, and non-motor symptoms. Together, our data suggests that in this family the A431E mutation leads to a divergent neurological disorder in which cognitive deterioration was clinically exceeded by motor impairment and that it involves early glial and vascular pathological changes.
